Peer review reports
From: Nanoparticle delivery of TFOs is a novel targeted therapy for HER2 amplified breast cancer
Original Submission | ||
---|---|---|
26 Jan 2023 | Submitted | Original manuscript |
11 Feb 2023 | Author responded | Author comments - Zan Shen |
Resubmission - Version 2 | ||
11 Feb 2023 | Submitted | Manuscript version 2 |
12 Mar 2023 | Reviewed | Reviewer Report - Muhammad Khan |
21 Mar 2023 | Reviewed | Reviewer Report |
11 Apr 2023 | Author responded | Author comments - Zan Shen |
Resubmission - Version 3 | ||
11 Apr 2023 | Submitted | Manuscript version 3 |
12 Apr 2023 | Author responded | Author comments - Zan Shen |
Resubmission - Version 4 | ||
12 Apr 2023 | Submitted | Manuscript version 4 |
13 May 2023 | Reviewed | Reviewer Report - Muhammad Khan |
21 Jun 2023 | Reviewed | Reviewer Report - João Conde |
29 Jun 2023 | Author responded | Author comments - Zan Shen |
Resubmission - Version 5 | ||
29 Jun 2023 | Submitted | Manuscript version 5 |
1 Jul 2023 | Author responded | Author comments - Zan Shen |
Resubmission - Version 6 | ||
1 Jul 2023 | Submitted | Manuscript version 6 |
Publishing | ||
13 Jul 2023 | Editorially accepted | |
20 Jul 2023 | Article published | 10.1186/s12885-023-11176-8 |